A Computational Framework for the Administration of 5-Aminovulinic Acid Before Glioblastoma Surgery

Area of Science:

• Biomedical Engineering
• Computational Biology
• Oncology

Background:

• 5-Aminolevulinic Acid (5-ALA) is an FDA-approved fluorophore for glioblastoma fluorescence-guided surgery.
• Current dosing relies on rodent studies, with peak signal observed around 6 hours post-administration.
• Optimizing 5-ALA administration timing and dosage is crucial for effective intraoperative imaging.

Purpose of the Study:

• To construct a computational framework simulating 5-ALA transport and conversion to protoporphyrin IX in glioblastoma.
• To investigate the impact of dose and timing on fluorescence signal for surgical guidance.
• To analyze how tumor characteristics influence 5-ALA administration strategies.

Main Methods:

• Development of a computational framework combining compartmental models and partial differential equations.
• Simulation of 5-ALA transport through the stomach, blood, and brain.
• Modeling of 5-ALA conversion to protoporphyrin IX at the tumor site.

Main Results:

• The computational model predicts peak fluorescent concentrations between 2-7 hours for detectable tumors.
• Results align with current surgical guidelines for 5-ALA administration.
• The framework allows examination of tumor size and location effects on dosage and timing.

Conclusions:

• The developed framework provides a tool for optimizing 5-ALA administration for glioblastoma surgery.
• Computational modeling can refine dosing strategies for enhanced fluorescence-guided procedures.
• This approach aids in tailoring 5-ALA administration based on individual patient and tumor factors.